NDC Compounded Drug 73271-1006-1 Lidocaine; Tetracaine; Benzocaine
Cream Topical
Compounded Drug Product Information
NDC Crossover Products Matching Lidocaine; Tetracaine; Benzocaine
NDC crossover of Benzocaine/lidocaine Hcl/tetracaine Hcl 20%/6%/4% with NDC 73271-1006 a human compounded drug with other similar products matching the same substance name (Lidocaine; Tetracaine; Benzocaine) and the same administration route (topical) or dosage form (cream).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
72682-2588-4 | Tridermacaine (20/6/4) Cream 120g | Tridermacaine (20/6/4) Cream 120g | 120 g in 1 BOTTLE, PUMP | Cream | Topical | Anazaohealth Corporation |
72682-2588-4 | Tridermacaine (20/6/4) Cream 120g | Tridermacaine (20/6/4) Cream 120g | 120 g in 1 BOTTLE, PUMP | Cream | Topical | Anazaohealth Corporation |
72682-2588-4 | Tridermacaine (20/6/4) Cream 120g | Tridermacaine (20/6/4) Cream 120g | 120 g in 1 BOTTLE, PUMP | Cream | Topical | Anazaohealth Corporation |
Frequently Asked Questions
What is the NDC number assigned to Tridermacaine (20/6/4) Cream 120g?
Tridermacaine (20/6/4) Cream 120g was assigned by its manufacturer with NDC product code 73271-1006. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Tridermacaine (20/6/4) Cream 120g?
The NDC package code 73271-1006-1 was assigned to a 1 CREAM in 1 BOTTLE, PUMP of lidocaine; tetracaine; benzocaine administered topical via cream.
Who manufactures this product?
Tridermacaine (20/6/4) Cream 120g is manufactured by an outsourced facility and labeled by Right Value Drug Stores Llc Dba Carie Boyd Pharmaceuticals. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by AnazaoHealth Corporation with NDC product codes 72682-2588-4, 72682-2588-4 and 72682-2588-4.